🔴 Indaptus Therapeutics is trading 5.41% down today with no clear company-specific announcement

Indaptus Therapeutics is trading 5.41% down at $3.36, with no clear company-specific announcement explaining the September 21 decline.

• It follows a close of $3.55 on September 18, 2026.
• The decline comes despite higher S&P 500, Nasdaq Composite, and Dow Jones Industrial Average.
• The recent approximately $24 million financing is stale and does not directly explain today’s weakness; recent coverage lists a director resignation effective September 2, not a new September 21 catalyst.